JETEMA (Korea) Top Management

216080 Stock  KRW 19,440  120.00  0.62%   
Analysis of JETEMA's management performance can provide insight into the company performance.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in JETEMA Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Symbol  216080
Name  JETEMA Co
TypeStock
Country  
 Republic of Korea
Exchange  KQ

Information on JETEMA Co Leadership is currently not available.

If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

JETEMA Management Team Effectiveness

The company has return on total asset (ROA) of (0.0179) % which means that it has lost $0.0179 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 43.438 %, meaning that it generated $43.438 on every $100 dollars invested by stockholders. JETEMA's management efficiency ratios could be used to measure how well JETEMA manages its routine affairs as well as how well it operates its assets and liabilities.

JETEMA Workforce Comparison

JETEMA Co is currently under evaluation in number of employees category among its peers. The total workforce of Pharmaceuticals industry is presently estimated at about 440. JETEMA adds roughly 0.0 in number of employees claiming only tiny portion of equities listed under Pharmaceuticals industry.
The company has Profit Margin (PM) of (0.21) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.07.

JETEMA Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. JETEMA Price Series Summation is a cross summation of JETEMA price series and its benchmark/peer.

About JETEMA Management Performance

The success or failure of an entity such as JETEMA often depends on how effective the management is. JETEMA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of JETEMA management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the JETEMA management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers botulinum toxins, fillers, anti-aging solutions, lifting threads for medical treatment, laser surgical instruments, and skin care hyaluronic acid masks. JETEMA is traded on Korean Securities Dealers Automated Quotations in South Korea.
Please note, the presentation of JETEMA's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, JETEMA's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of JETEMA's management manipulating its earnings.

Complementary Tools for JETEMA Stock analysis

When running JETEMA's price analysis, check to measure JETEMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy JETEMA is operating at the current time. Most of JETEMA's value examination focuses on studying past and present price action to predict the probability of JETEMA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move JETEMA's price. Additionally, you may evaluate how the addition of JETEMA to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals